CNBC’s Jim Cramer delivers his daily Mad Dash.
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Veteran biosensor innovator and technology leader brings decades of experience developing and scaling breakthrough ...
Kenai Therapeutics, a clinical-stage biotechnology company pioneering next generation approaches to cure neurological conditions, today announced the completion of enrollment for the REPLACE™ Phase 1b ...
In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...
Sponsored reels, algorithmic recommendations, and predatory marketplace listings routinely flood digital feeds, promising ...
DSS Takara Bio India marks 15 years of powering India’s molecular biology revolution: Our Bureau, Bengaluru Tuesday, July 7, 2026, 17:15 Hrs [IST] DSS Takara Bio India. (DTI), t ...
Industrial SalesLeads’ June 2026 report on planned capital project spending shows continued momentum in the Industrial ...
Taiwan pavilion to present 40+ technologies from 33 companies at the world's largest biotechnology convention SAN DIEGO, June 22, 2026 /PRNewswire/ -- Taiwan is showcasing the strength of its ...
Eupraxia Pharmaceuticals Inc. ('Eupraxia' or the 'Company') (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Ancient evidence suggests a new twist in how we all got here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results